Therapeutic for Rett syndrome shows success in preclinical mouse models
Scientists at IDIBELL have reported preclinical success as Mecp2 deficiency in a mouse model is partially rescued following treatment with a novel drug candidate.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.